Citation:Cooper WA, O'toole S, Boyer M, Horvath L, Mahar A 2011

Citation

Cooper WA, O'toole S, Boyer M, Horvath L, Mahar A. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements. Pathology 2011 Feb;43(2):103-15 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21233671.

Critical appraisals

• Assign a critical appraisal

Cited by

1. What specimen types are suitable for mutation testing in NSCLC patients?
2. When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?
3. Which histological subtype should undergo mutation testing?